Sciclone Pharmaceuticals, Inc. (SCLn) Tops Q1 EPS by 1c

Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLn) reported Q1 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $39.2 million versus the consensus estimate of $37.08 million.

For earnings history and earnings-related data on Sciclone Pharmaceuticals, Inc. (SCLn) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• CoStar Group acquires Zonda for $800M, adding new home data
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'